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Abstract
The uterine corpus represents the most common site for tumour development in the female
genital system. Uterine neoplasms are categorised as epithelial, mesenchymal, mixed epi-
thelial-mesenchymal or trophoblastic tumours. In this study we employed a mouse genetic
approach using the MuLE lentiviral gene regulatory system to functionally test the ability of
ecotropic lentiviruses to model epithelial and mesenchymal uterine malignancies ex vivo
and in vivo. We discovered that MuLE lentiviruses efficiently infect uterine stromal cells but
not endometrial epithelial cells when injected into the uterus of cycling, pseudopregnant or
ovarectomized mice. Consistent with this cellular infection spectrum, we show that intra-
uterine injection of ecotropic MuLE viruses expressing oncogenic HrasG12V together with
knockdown of Cdkn2a induce high-grade endometrial stromal sarcomas. These findings
establish this approach as an efficient method of generating autochthonous mouse models
of uterine sarcomas and in general for performing genetic manipulations of uterine stromal
cells in vivo.
Introduction
Early-stage uterine tumours are associated with an excellent prognosis after surgical treatment.
However, for patients with advanced, metastatic or recurrent uterine cancer, limited therapeu-
tic options are available [1,2]. To improve understanding of these diverse diseases it would be
desirable to have a series of representative mouse models that reflect not only the different his-
tological types of uterine tumours but also the underlying molecular genetics of each of these
different tumour types. In recent years there has been some progress towards this goal.
The most prevalent tumours of the female reproductive system are carcinomas of the endo-
metrium, which are classified in a dualistic model based on histological appearance and
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molecular differences [1]. Type I endometrioid tumours account for 80% of endometrial
malignancies and are characterised by a relatively high survival rate, due partly to their fre-
quent early detection following abnormal uterine bleeding. Several studies report that PTEN
mutations occur early in the development of type I tumours [3–5]. In terms of generating
rapid, flexible and accurate mouse models of this disease, it has been shown that the injection
of adenoviruses expressing Cre into the uterine lumen of adult Ptenfl/fl mice caused the devel-
opment of uterine carcinomas [6]. Tumour onset and severity can be accelerated by combin-
ing Pten deletion with Kras activation [7]. This combination of germline-based generation of
Cre-regulatable genetic alleles plus viral-based delivery of Cre to somatic endometrial cells rep-
resents one approach to speed up the generation of mouse models of different molecular
forms of endometrial carcinoma. Type II endometrial tumours are more common in older,
non-obese women and, despite their rarity, have a worse outcome due to their highly invasive
and metastatic nature. They comprise three different subtypes: serous, clear cell and undiffer-
entiated carcinomas, each representing approximately 5–10% of all endometrial carcinoma
cases [1]. Type II tumours are associated with both overlapping and distinct sets of genetic
alterations to those found in type I tumours. They exhibit extensive somatic copy number
alterations. In contrast to type I tumours, type II tumours are frequently characterised by early
mutations in TP53 [8–10]. The deletion of the Trp53 gene in the mouse endometrium results
in the formation of all histological subtypes of type II disease after 14–16 months [11].
Uterine mesenchymal tumours account for 3% of uterine tumours and are derived from
the soft tissue of the uterine corpus, which comprises endometrial stroma, smooth muscle and
blood vessels [12]. Uterine sarcomas are broadly classified as leiomyosarcomas, accounting for
60% of cases, endometrial stromal sarcomas, and undifferentiated sarcomas. These categories
are defined by the presence of specific molecular alterations as well as by tumour morphology
and prognosis [13]. Leiomyosarcomas are composed of cells which demonstrate smooth mus-
cle differentiation. The majority of uterine leiomyosarcomas occur sporadically. Commonly
found alterations include MED12,HMGA2 and PTEN [14–16]. Patients with germline muta-
tions in fumarate hydratase (FH) have an increased risk of developing uterine leiomyosarco-
mas as well as uterine leiomyomas [17].
Endometrial stromal sarcomas are composed of cells resembling the endometrial stroma
and are far less frequent than smooth muscle tumours, such as leiomyosarcomas. They are
characterized by chromosomal translocations, most commonly involving the zinc finger genes
JAZF1 and SUZ1 [18,19]. Undifferentiated uterine sarcomas represent a very rare and aggres-
sive category of uterine tumours. Considering their low incidence rate, there is little to no
information about molecular alterations found in these tumours. They are diagnosed by exclu-
sion after elimination of other high-grade uterine tumours with a sarcomatous component
[20,21]. However, again using the approach of combined germline genetics plus viral delivery
of Cre, injection of an adenovirus expressing Cre-recombinase into the uterus of mice har-
bouring conditional alleles of oncogenic Kras and Trp53 caused the development of undiffer-
entiated pleomorphic sarcoma [22,23].
In order to accelerate the process of generating genetically-complex autochthonous mouse
models of human tumours we recently developed the MuLE lentiviral gene regulatory system,
that facilitates combinatorial somatic genetics in cultured cells and in vivo in mouse tissues. As
a proof of principle, we showed that this system could be employed to generate new mouse
models of muscle-derived undifferentiated sarcomas that harbour alterations in multiple sig-
nalling pathways [24]. In the current study we investigated whether the MuLE system could
also be applied to the setting of modelling of different forms of uterine tumours. We show that
the MuLE system can be used to model endometrial sarcomas but does not appear to be easily
applicable to modelling of uterine carcinomas.
Modelling uterine sarcoma in mice
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Materials and methods
Mice
SCID/beige mutant mice (C.B-17/CrHsd-PrkdcScidLystbg-J) and C57BL/6JRccHsd mice were
obtained from Envigo. B6.Cg-Gt(ROSA)Sortm14(CAG-tdTomato)Hze/J mice were obtained from
the Jackson Laboratory. Vasectomized RjOrl:SWISS male mice were obtained from Janvier
labs. Pax8-rtTA; LC1 mice [25], were obtained from Prof. Carsten Wagner, University of
Zurich. For doxyclycline experiments, 6–8 week-old offspring of intercrosses between
Pax8-rtTA; LC1 and B6.Cg-Gt(ROSA)Sortm14(CAG-tdTomato)Hze/J mice were exposed to doxycy-
cline (0.5 mg/ml) in drinking water supplemented with 5% sucrose for 5 days. Afterwards ani-
mals were kept on normal drinking water for another week. Mouse experiments were
approved by the Veterinary Office of the Canton of Zurich under the licence 137/2013.
Ovarectomy
Adult, cycling female B6.Cg-Gt(ROSA)Sortm14(CAG-tdTomato)Hze/J mice were anaesthetized with
isoflurane and the ovaries were exposed. Both uterine horns were ligated and the ovaries were
removed. 2 weeks following surgery lentiviruses were injected into the uterus.
Intrauterine viral injections
Approximately 4 week-old female mice were anaesthetized using isoflurane and the uteri were
exposed by making a small incision. 10 μL of concentrated lenti- and adeno-viruses expressing
different genetic manipulations were injected into one uterine horn with a 30G insulin syringe.
The animals were euthanised 1–6 months after injection depending on the experiment. The
uteri were harvested, fixed in 10% formalin, paraffin-embedded and cut in 5 μm thick sections.
For the identification of the Cre-infected cells, B6.Cg-Gt(ROSA)Sortm14(CAG-tdTomato)Hze/J
uteri were fixed in 4% paraformaldehyde for 4–6 h, transferred to 30% sucrose overnight,
embedded in OCT and cut in 5 μm thick sections.
Allograft studies
For allograft experiments, 8 week-old female SCID/beige mice were anaesthetized by the inha-
lation of 2.5% isoflurane and 1x106 cells resuspended in 50% Matrigel (BD, no. 354230, Eysins,
Switzerland) were injected subcutaneously in a total volume of 150 μL. In vivo imaging as well
as a caliper were used to follow tumour development over time.
In vivo imaging studies
Noninvasive in vivo fluorescence and bioluminescence imaging was performed using the IVIS
Spectrum (Perkin Elmer, Waltham, MA) together with the Living Image software (version
4.4). Mice were anaesthetized by using 2.5% isoflurane. During imaging, the isoflurane levels
were reduced to 1.5%. All fluorescence measurements were performed in epi-fluorescence
mode. For bioluminescence imaging, mice were injected subcutaneously with 150 mg/kg D-
luciferin (Caliper, no. 122796, Waltham, MA) and imaged 15 min after injection. For the
quantification of the total radiant efficiency, a region of interest was drawn around the mouse
and the total radiant efficiency was automatically detected.
Isolation and maintenance of pEEC
We used previously published protocols [26,27] with minor modifications for the isolation of
primary endometrial epithelial cells from mice. Five to ten 3-week-old C57BL/6 mice were
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sacrificed by cervical dislocation and uterine horns were taken out, dissected in Hanks Bal-
anced Salt Solution (HBSS, ThermoScientific, Waltham, MA) and cut open lengthwise. The
fragments were then pooled and incubated with 0.5% Trypsin (Sigma Aldrich, St. Louis, MO)/
2.5% pancreatin (Thermo Fisher Scientific, Waltham, MA) in HBSS for 60 min at 4˚C and 60
min at 22˚C. Digested uteri were transferred to ice-cold HBSS and vortexed for 30 sec to
release epithelial cells. Uterine tissues were filtered through a 40 μm nylon mesh and epithelial
cells were collected and centrifuged at 1.000 g for 5 min. Cells were then resuspended in basal
medium containing DMEM/F12 (Sigma Aldrich, St Louis, MO) supplemented with 1 mmol/l
HEPES (Thermo Fisher Scientific, Waltham, MA) and 1% penicillin/streptomycin (Sigma
Aldrich, St Louis, MO). Cells were mechanically disrupted by pipetting until clumps of cells
are observed under the microscope. Cells were then seeded in basal medium supplemented
with 5 ng/ml EGF (PeproTech, Hamburg, Germany), 1 mg/ml insulin (Sigma Aldrich, St
Louis, MO), 0.55 mg/ml transferrin (Sigma Aldrich, St Louis, MO), 0.5 μg/ml sodium selenite
(Sigma Aldrich, St Louis, MO) (BIE—basal medium, ITS supplement and EGF) and 0.5% dex-
tran-coated charcoal-stripped FCS (Biochrom AG, Berlin, Germany) and plated into cultures
dishes. Cells were cultured in BIE plus 0.5% stripped FCS in an incubator at 37˚C with saturat-
ing humidity and 5% O2.
Immunohistochemistry
Immunohistochemical analysis was performed on formalin-fixed paraffin sections after anti-
gen retrieval (5 min at 110˚C in 0.1 M citrate buffer pH 6) and immunofluorescence on cells
(IF-IC) and frozen sections (IF-F) on paraformaldehyde-treated cells or sections. The antibod-
ies used in this study were anti-CD10 antibody (1:2000, PA5-47075, Thermo Fisher Scientific,
Waltham, MA), anti-CD31 antibody (1:200, ab28364, abcam, Cambridge, UK), anti-CYCLIN
D1 antibody (1:40, SP4, Thermo Fisher Scientific, Waltham, MA), anti-DESMIN antibody
(1:100, D1033, Sigma-Aldrich, Darmstadt, Germany), anti-MYOD1 antibody (1:100, M3512,
Dako, Santa Clara), anti-MYOGENIN antibody (1:500, M3559, Dako, Santa Clara), anti-
alpha-SMOOTH MUSCLE ACTIN antibody (1:5000, ab5694, abcam, Cambridge, UK), anti-
H-RAS antibody (1:100, GTX116041, GeneTex, Irvine, CA) and anti-VIMENTIN antibody
(1:500, D21H3, Cell Signaling, Danvers, MA).
Results
Establishment of a primary endometrial epithelial cell culturing system
To study the ability of the MuLE system to model uterine malignancies, we first focused on the
most common uterine tumour type, endometrial carcinoma. We established a murine endo-
metrial epithelial cell culture model to allow us to study endometrial tumour development ex
vivo. Freshly isolated cultures of primary endometrial epithelial cells (pEECs) showed almost
uniform postive staining for E-CADHERIN, ß-CATENIN and CYTOKERATIN-7 and, with
the exception of a small number of cells, negative staining for VIMENTIN, establishing the rel-
ative purity of the epithelial isolation (Fig 1A). Next, we optimised cell culture conditions to
allow the proliferation of these cells. The addition of 0.5% charcoal-stripped FCS to the
medium allowed expansion of the cells into larger clusters in which cells maintained their epi-
thelial cobblestone morphology. If FCS was not added the cells maintained their epithelial
morphology but did not expand and passaging them was not possible (Fig 1B). Based on these
results, we decided to culture the cells with 0.5% FCS.
The extended replicative life span which results from the inactivation of the p53 pathway is
thought to represent an important event in the multistep process of endometrial carcinoma
development. Given this genetic link to human endometrial carcinogenesis and additionally
Modelling uterine sarcoma in mice
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since pEECs fall into senescence with ongoing cultivation on plastic dishes [28], we tried to
immortalise them by using primary epithelial cultures prepared from Trp53fl/fl uteri. Trp53
was deleted ex vivo by treating the cells with a Cre-expressing adenovirus. Additionally, in a
parallel approach, we infected pEECs from wildtype mice with a MuLE vector expressing a
miR-30-based shRNA against Trp53 together with drug resistance. Genetic deletion or knock-
down of Trp53 allowed the cells to be expanded and passaged, but passaging still caused a
change in cellular morphology to a more fibroblast-like appearance (Fig 1C), meaning that
these cultures do not represent a system that can be used for long-term studies of endometrial
epithelial cells.
We next sought to determine whether primary endometrial epithelial cells could be readily
infected by MuLE viruses. For these experiments we isolated endometrial epithelial cells from
uteri of Pax8-rtTA; LC1; ROSA26-lox-stop-lox tdTomato mice [25,29]. PAX8 is a transcrip-
tion factor which is essential for the development of the female genital tract, including luminal
and glandular endometrial epithelial cells [30]. In this mouse model, the reverse tetracycline-
controlled transactivator (rtTA) is expressed under the control of the Pax8 promotor (Pax8-
rtTA). In the presence of doxycycline, rtTA can bind to a tetracycline response element (TRE)
which leads to the expression of Luciferase and Cre, specifically in endometrial epithelial cells,
which induces the expression of tdTomato (Fig 2A). Following the administration of female
mice with doxycycline to activate Cre-mediated recombination, uteri were harvested and
Pax8-driven tdTomato expression in glandular and luminar epithelial cells was confirmed by
in vivo imaging (Fig 2B) and microscopy. We isolated pEECs from the uteri of these mice and
Fig 1. Establishment of a primary endometrial epithelial cell culturing system. (A) pEECs stain
positively for the epithelial cell markers E-CADHERIN, ß-CATENIN and CYTOKERATIN-7 and negatively for
the stromal cell marker VIMENTIN. Bright field image (10x) scale bar: 50 μm, low magnification (20x) scale
bar: 100 μm and high magnification (63x) scale bar: 100 μm. (B) Supplementing BIE with 0.5% FCS promotes
growth. BIE: basal medium supplemented with insulin, EGF, transferrin und sodium selenite. Scale bar:
50 μm. (C) Adeno-Cre-treated pEECs from Trp53fl/fl mice and pEECs infected with a lentivirus expressing a
miR-30-based shRNA against Trp53 were immortalised and could be expanded but lost epithelial
morphology. Scale bar: 50 μm.
https://doi.org/10.1371/journal.pone.0186102.g001
Modelling uterine sarcoma in mice
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Fig 2. Lentiviral transduction of cultured uterine cells strongly favors stromal cells. (A) Schematic diagram of
Pax8-rtTA-mediated doxycycline-controlled Cre-expression in Pax8-rtTA; LC1; ROSA26-lox-stop-lox tdTomato mice. (B)
Doxycycline activates Cre-mediated recombination in glandular und luminar epithelial cells in the endometrium shown by
whole organ imaging (left panel) and imaging of frozen histological sections (right panels). Scale bar: 100 μm. (C) Bright field
and fluorescence images 1, 4, 6, 11 and 25 days after the isolation of pEECs from the uteri of doxycycline-treated Pax8-rtTA;
LC1; ROSA26-lox-stop-lox tdTomato mice. pEECs were infected on day 1 with ecotropic lentiviruses expressing either GFP
Modelling uterine sarcoma in mice
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infected them with ecotropic MuLE lentiviruses expressing GFP to label infected cells, After 48
hours only a few Pax8-tdTomato-expressing cells were GFP-positive but the majority of GFP-
expressing cells were Pax8-tdTomato-negative (Fig 2C, top half), demonstrating that infection
of epithelial cells by MuLE viruses is rare.
We nonetheless reasoned that it might be possible to transform epithelial cells and poten-
tially create an ex vivo engineered endometrial carcinoma model by infecting pEECs with an
ecotropic MuLE virus expressing shCdkn2a plus HrasG12V, taking advantage of the fact that
largely mutually exclusive genetic alterations in KRAS, HRAS, NRAS, BRAF and NF1 occur in
about 32% of human endometrial carcinomas (www.cbioportal.org) and loss of function of
Cdkn2a in mouse cells allows escape from RAS-induced senescence and transformation
[31,32]. Infection of the above-described genetically labelled pEEC cultures with the shCdkn2a
and HrasG12V-expressing lentivirus led to the emergence of a population of apparently trans-
formed cells that proliferated rapidly, could be sequentially passaged and formed stream-like
structures in culture, however these cells were negative for tdTomato expression (Fig 2C,
lower half), indicating that they are not epithelial in origin. It is known that endometrial epi-
thelial cell cultures can be contaminated by small numbers of endometrial stromal cells and
indeed, when these transformed cells were injected subcutaneously into SCID/beige mice they
formed tumours with a sarcoma-like morphology. Histologically, the tumours stained nega-
tively for CD31, DESMIN, MYOD1, MYOGENIN, alpha-SMA and positively for VIMENTIN
(Fig 2D). This molecular phenotype is consistent with a diagnosis of undifferentiated sarcoma
of likely mesenchymal cell origin. We conclude that while endometrial epithelial cells can be
infected by MuLE viruses, albeit at low efficiency, transformation of other stromal cell types
present in these cultures occurs efficiently by HrasG12V overexpression and Cdkn2a
knockdown.
Stromal cells are preferentially transduced by lentiviruses following in
vivo injection
To study the efficacy of ecotropic lentiviral infection in vivo, we first injected mice with GFP-,
tdTomato- or Luciferase-expressing ecotropic lentiviruses, but we were unable to detect the
expression of any of these markers by immunofluorescence staining. However, using R26-lox-
STOP-lox-tdTomato mice [29] as a reporter system (Fig 3A) to test cellular infection, we dis-
covered that the injection of ecotropic lentiviruses expressing Cre into the uterus of cycling
(n = 3), pseudopregnant (n = 1) and ovarectomized (n = 1) mice induced tdTomato expression
in cells in the uterine stroma but did not lead to infection of endometrial epithelial cells (Fig
3B, first column). Since it has been shown that adenoviruses can infect stromal and epithelial
cells in vivo [6,22,33], we injected adenovirus expressing Cre into the uterus of cycling (n = 2),
pseudopregnant (n = 1) and ovarectomized (n = 1) mice as a positive control (Fig 3B, second
column). In ovarectomized mice we were indeed able to detect tdTomato-positive epithelial
cells but again there were many more positive stromal cells. We conclude that lentiviral and
adenoviral intra-uterine injections strongly favour infection of stromal cells rather than epithe-
lial cells, even in mice in which endometrial cycling was hormonally blocked (ovarectomy,
pseudopregnancy) to prevent the loss of potentially infected epithelial cells.
or shCdkn2a plus HrasG12V and Luciferase. Scale bar: 50 μm. (D) Ability of shCdkn2a and HrasG12V-transduced cells to form
tumours within 47 days in allograft experiments (visualised using luciferase imaging in the left panel). Right panels show H&E
and immunohistochemical stainings using the indicated antibodies. Low magnification scale bar: 1 cm and high magnification
scale bar: 100 μm.
https://doi.org/10.1371/journal.pone.0186102.g002
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Intrauterine injection of MuLE viruses expressing shCdkn2a plus
HrasG12V causes sarcoma development
Given the data obtained above, we reasoned that it might be possible to generate a mouse
model of uterine sarcomas. Since MuLE lentiviruses can be used to model undifferentiated
pleomorphic sarcomas in vivo [24], a tumour of mesenchymal origin [22], concentrated eco-
tropic MuLE lentiviruses which cause either Cdkn2a silencing together with activation of
HrasG12V or Pten or Trp53 silencing alone, were injected into the uterus of 4-week-old SCID/
beige mice (Fig 4A). Additionally, the MuLE vectors carried a coding sequence for firefly lucif-
erase in order to label infected cells and to trace tumour development over time. The injection
of the shCdkn2a plus HrasG12V expressing ecotropic MuLE lentivirus into the uterus of five
SCID/beige mice caused the development of high-grade endometrial stromal sarcomas with
80% (n = 4 tumours) penetrance after less than two months (median overall survival 49 days)
(Fig 4B, 4D and 4E). This process was monitored by an increase in luciferase expression over
time (Fig 4C). Tumours had maximum diameters between 3–6 mm at the time of sacrifice of
the mice. Tumours expressed high levels of H-RAS (S1 Fig) compared to normal uterine tissue,
Fig 3. Stromal cells are preferentially transduced by lentiviruses following in vivo injection. (A)
tdTomato fluorescence signal in the uterus following intrauterine injection of ecotropic virus expressing Cre.
(B) Intrauterine injection of ROSA26-lox-STOP-lox-tdTomato mice with Cre-expressing lenti- and
adenoviruses. Arrowheads indicate infected epithelial cells. Scale bar: 100 μm. CTRL indicates non-injected
animals.
https://doi.org/10.1371/journal.pone.0186102.g003
Modelling uterine sarcoma in mice
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Fig 4. HrasG12V expression plus knockdown of Cdkn2a causes high-grade endometrial stromal sarcomas. (A) Schematic
of MuLE vectors simultaneously expressing a combination of shRNA against Cdkn2a plus expression of HrasG12V or expressing
shRNAs against Trp53 or Pten or a non-silencing (n.s.) control shRNA. All vectors also expressed Luciferase. Numbers of mice
that were injected with each vector are shown in the figure. (B) Quantification (mean ± SD) of luciferase signal over time.
† Sacrifice of all mice in this group by this time point. (C) Bioluminescence imaging in two mice 7, 22, 28, 34 and 42 days after the
injection of MuLE lentiviruses expressing shRNA against Cdkn2a together with HrasG12V into the uterus of 6-8-week-old SCID/
Modelling uterine sarcoma in mice
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confirming the functionality of the MuLE vector. Histologically, the tumours were highly cel-
lular showing a diffuse growth pattern, delicate slit-like capillary network (Fig 4J, and extensive
myometrial invasion. In addition, tumors were rapidly growing (Ki-67 proliferation fraction
of 10–50%, S2A Fig) with high-grade cytologic atypia, resembling endometrial stromal sar-
coma. Besides hemosiderin deposits (S2B Fig), they stained positively for CYCLIN D1 (Fig
4G), diffusely positively for CD10 (Fig 4H) and VIMENTIN (Fig 4I) and negatively for CD31
(Fig 4J), DESMIN (Fig 4K), MYOGENIN (Fig 4L) and alpha-SMA (Fig 4M). These cellular
and molecular features are consistent with a diagnosis of high grade endometrial stromal sar-
coma. Lesions showed an absence of mucin inclusions (S2C Fig), which ruled out an adenocar-
cinoma phenotype. Tumours did not show staining for smooth muscle cells or collagen by van
Gieson‘s staining (S2D Fig) further indicating that these tumours are not leimyosarcomas.
None of the other injected vectors expressing knockdown constructs for two of the most com-
monly altered genes in endometrial carcinoma patients, namely Pten or Trp53, were sufficient
to cause any large increases in luciferase signal over time and to induce tumour formation
within 6 months after injection (Fig 4B). The development of endometrial stromal sarcoma by
the injection of shCdkn2a plus HrasG12V expressing ecotropic lentiviruses serves as a technical
proof-of-principle that this approach can be used to model uterine sarcomas.
To further investigate the potential utility of this approach for modelling other types of
uterine malignancies we generated a series of five different MuLE lentiviruses designed to
reproduce the genetics of uterine leiomyomas and uterine leiomyosarcomas, namely i) overex-
pression of HMGA2, ii) expression of MED12G44S, iii) expression of MED12G44S plus shRNA
against Trp53, iv) expression of shRNA against Fh or v) expression of shRNA against Fh plus
shRNA against Cdkn2a. Each vector also expressed luciferase. Each of these vectors were
injected into uteri of ten or eleven mice for the HMGA2 and MED12 experiments and three
mice for the Fh experiments and the mice were monitored by luciferase imaging for 9–11
months. None of these animals showed any increase in luciferase signal nor any histological
abnormalities, arguing that this approach is not likely to be useful for modelling uterine
leiomyomas.
Discussion
In this study we employed a mouse genetic approach using the MuLE lentiviral gene regulatory
system [24] to functionally test the ability of ecotropic lentiviruses to model epithelial and mes-
enchymal uterine malignancies ex vivo and in vivo.
A major problem in ex vivo endometrial cell culture-based studies are contaminating stro-
mal cells, which are a byproduct of the isolation. While epithelial cells lose their proliferative
capacity during ongoing cultivation on plastic, stromal cells are more easily cultured long term
[28]. A Rho kinase inhibitor (ROCK), in combination with fibroblast feeder cells, induces
epithelial cells from many tissues to proliferate indefinitely ex vivo, without the need to immor-
talise them [34,35]. The culture of pEECs with conditional reprogramming by feeder cells
and ROCK inhibitor did not improve the culture system in our hands. Despite some minor
growth in culture, pEECs displayed strong degenerative changes, such as giant intra-nuclear
vacuoles, and did not survive the first passage in culture. Since it was not possible to expand
and passage pEECs which retain lineage commitment and normal growth, we tried to generate
beige mice. Injected mice developed tumours (n = 4) with 80% penetrance. Median overall survival was 49 days. (D)
Bioluminescence imaging and photographs of tumour-bearing uterus at the time of sacrifice (day 56 after injection). (E-M) H&E
and immunohistochemical stainings of tumours from two different mice using the indicated antibodies. Low magnification scale
bar: 1 mm and high magnification scale bar: 100 μm.
https://doi.org/10.1371/journal.pone.0186102.g004
Modelling uterine sarcoma in mice
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immortalised cell lines through Trp53 tumour suppressor inactivation or Hras oncogene acti-
vation with the use of ecotropic lentiviruses. This approach did not work, possibly due to the
fact that ecotropic lentiviruses seem to efficiently infect contaminating stromal cells.
We also discovered that MuLE lentiviruses efficiently infect uterine stromal cells but not
endometrial epithelial cells when injected into the uterus of cycling, pseudopregnant or ovar-
ectomized mice. Consistent with this cellular infection spectrum, we show that intra-uterine
injection of ecotropic MuLE viruses expressing oncogenic HrasG12V together with knockdown
of Cdkn2a induce high-grade endometrial stromal sarcomas. This model is analagous to a sim-
ilar aggressive uterine soft tissue sarcoma model that was previously generated through a Cre-
loxP germline strategy. In this model, uterus-specific deletion of Trp53 was combined with
expression of a constitutively active form of Kras [22]. The advantage of the MuLE system is
that it is not dependent on the prior generation of germline-modified, Cre-regulatable mice
and is therefore better suited to higher throughput testing of the pathological effects of differ-
ent combinations of genetic alterations.
A theoretical drawback of the use of lentiviral vectors is the possibility of insertional muta-
genesis. We refer to our previous detailed discussion of this issue [24] with respect to the fact
that lentiviral vectors appear to be much less problematic than retroviral vectors. Data pre-
sented in this study also support the fact that insertional mutagenesis is unlikely to be a com-
plicating factor. While MuLE viruses expressing HrasG12V plus shCdkn2a induced tumours at
high frequency (4 of 5 mice), we injected a total of 53 mice with numerous vectors designed to
manipulate a variety of known cancer-relevant genes and did not observe a single tumour in
any mouse. This underlines the specificity of the HrasG12V plus shCdkn2a tumour phenotype
and further demonstrates lack of non-specific tumour formation of the MuLE system in
general.
Since we have previously shown that ecotropic MuLE vectors can infect a wide variety of
epithelial and non-epithelial cell types [24], it remains unclear why endometrial epithelial cells
are resistant to infection. It has been shown that mucin, a glycoconjugate, inhibits the entry of
lenti- and adenoviruses into epithelial cells and that viral transduction could be improved by
pretreating either the cells or the virus with the glycolyse hydrolase neuraminidase before
infection [36,37]. It would be worth testing in the future if the pretreatment of either ecotropic
lentiviruses or pEECs with neuraminidase increases epithelial cell transduction. In vivo studies
have shown that adenoviral vector infection efficiency is influenced by the stage of the estrous
cycle at the time of injection, with best results occuring during late metestrous and diestrous
stages of the estrous cycle [33]. During the estrous cycle apoptosis is increased ten-fold in the
luminar epithelium compared to other cell compartments [38]. Even if epithelial cells were ini-
tially infected, the high rates of apoptosis may lead to the rapid loss of these cells during the
cycle. By the use of R26-lox-STOP-lox-tdTomato mice [29] as a reporter system to test cellular
infection, we discovered that the injection of ecotropic lentiviruses expressing Cre into the
uterus of cycling, pseudopregnant and ovarectomized mice induced tdTomato expression in
stromal cells but not epithelial cells regardless of stage of the estrous cycle and the viral dose.
In rodent cells a cationic amino acid transporter, termed CAT1, serves as the receptor for the
envelope glycoprotein gp70 of ecotropic MMLV [39]. In the endometrium CAT1 is expressed
on the basal surface of the epithelial cells [40]. Limited accessibility of CAT1 is another possible
reason why we were not able to infect epithelial cells in vivo. Additionally, we injected Cre-
liposome complexes into the uterine lumen of pseudopregnant and ovarectomized mice but
also with this approach we detected reporter gene activity only in stromal cells.
Only when we injected Cre-expressing adenoviruses in ovarectomized mice, were we able
to see not only tdTomato-positive stromal cells but also very few positive epithelial cells. This
confirmed the earlier observations that adenoviruses infect only few epithelial cells and many
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more stromal cells when injected in the uterus of lacZ reporter mice [6]. The injection of an
adenovirus expressing Cre into the uterus of Ptenfl/fl mice caused Pten deletion in both stromal
and epithelial cells, however this treatment caused endometrial carcinoma development, but
none of the injected uteri exhibited stromal tumours. This indicates that the deletion of Pten in
stromal cells does not offer an advantage to the cells and therefore is not selected for in terms
of causing a tumour [6]. Our studies in which injected ecotropic MuLE lentiviruses expressing
shPten failed to induce stromal tumours when injected into the uterine lumen of SCID/beige
mice are consistent with these data.
In summary, we discovered that ecotropic MuLE lentiviruses are able to inefficiently trans-
duce epithelial cells ex vivo and that infection strongly favors stromal cells. The injection of
ecotropic lentiviruses into the uterus of mice infected stromal cells but not epithelial cells
regardless of stage of the estrous cycle. The MuLE system appears to be suited for use in model-
ling endometrial sarcomas but not carcinomas and in general represents a rapid method for
performing complex genetic manipulations in uterine stromal cells in vivo.
Supporting information
S1 Fig. H-RAS expression in tumours. Immunohistochemical staining of two tumours from
two different mice as well as adjacent normal uterine tissue using anti-H-RAS antibody.
(TIF)
S2 Fig. Generation of high-grade endometrial stromal sarcomas. (A) Uterine tumours from
two different mice show increased proliferation (Ki67 immunohistochemistry), (B) hemosid-
erin deposition (Prussian blue staining), (C) absence of mucin inclusions (Alcian Blue PAS
staining) and (D) absence of strong staining for smooth muscle cells in yellow and collagen in
red (van Gieson‘s staining). Scale bar: 100 μm.
(TIF)
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